Omada Health, Inc. (OMDA) Price & Analysis

Compare

164 Followers

OMDA Stock Chart & Stats

$13.51

-$4.40(-19.47%)

At close: Jun 10 4:00 PM EDT

$13.51

-$4.40(-19.47%)

Day’s Range― - ―

52-Week Range$10.28 - $28.40

Previous Close$18.29

Volume2.54M

Average Volume (3M)1.67M

Market Cap

$796.08M

Enterprise Value$597.03M

Total Cash (Recent Filing)$222.04M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta2.07

Next Earnings

May 14, 2026

EPS Estimate

-0.08

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.08

Shares Outstanding58,925,438

10 Day Avg. Volume1,975,828

30 Day Avg. Volume1,669,012

Financial Highlights & Ratios

PEG Ratio0.97

Price to Book (P/B)4.01

Price to Sales (P/S)3.54

P/FCF Ratio54.46

Enterprise Value/Market Cap0.75

Enterprise Value/Revenue2.29

Enterprise Value/Gross Profit3.50

Enterprise Value/Ebitda-92.11

Forecast

1Y Price Target

$22.67

Price Target Upside67.80% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

EPS Forecast (FY)0.06

Revenue Forecast (FY)$319.18M

Bulls Say, Bears Say

Bulls Say

GLP-1 Flex Care Pricing And MarginsThe GLP-1 Flex Care program charges employers higher fees for clinical and behavioral support, which is expected to increase revenue per enrolled member and lift gross margins.

Product Expansion And Distribution PartnershipsExpansion into cholesterol and GLP-1 support services, coupled with AI-driven engagement and a partnership with a major pharmacy benefits manager, creates a large under-penetrated market opportunity that can drive sustained revenue growth.

Profitability And Cash FlowAchievement of positive EBITDA, GAAP net income, and free cash flow signals a move to sustainable profitability and lowers execution risk for investors.

Bears Say

Near-term Investment Pressure On MarginsPlanned increases in business investment may compress margins before the revenue benefits from those initiatives are realized.

One-time Items And Revenue Quality ConcernsReported results included a one-time customer negotiation benefit and only a modest topline beat after adjustment, which may raise questions about the durability of revenue growth.

Sector Valuation HeadwindsBroad valuation compression across healthcare technology stocks and lingering investor skepticism could limit multiple expansion despite improving company fundamentals.

Omada Health, Inc. News

Omada Health price target lowered to $26 from $32 at JPMorgan

JPMorgan lowered the firm’s price target on Omada Health (OMDA) to $26 from $32 and keeps an Overweight...

12d ago

OMDA

Omada Health price target lowered to $20 from $25 at Evercore ISI

Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Omada Health (OMDA) to $20 from $25...

18d ago

OMDA

Omada Health price target lowered to $18 from $27 at BMO Capital

BMO Capital analyst Sean Dodge lowered the firm’s price target on Omada Health (OMDA) to $18 from $27...

18d ago

OMDA

Omada Health price target lowered to $30 from $32 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Omada Health (OMDA) to $30 from $32 and keeps an...

18d ago

OMDA

Omada Health price target lowered to $22 from $28 at Canaccord

Canaccord lowered the firm’s price target on Omada Health (OMDA) to $22 from $28 and keeps a Buy...

18d ago

OMDA

Omada Health price target raised to $18 from $17 at Barclays

Barclays raised the firm’s price target on Omada Health (OMDA) to $18 from $17 and keeps an Overweight...

18d ago

OMDA

Omada Health announces GLP-1 Flex Care for employers

Omada Health (OMDA) announced GLP-1 Flex Care, a new offering that will support employers looking to increase access...

19d ago

OMDA

Omada Health reports Q4 EPS 8c, consensus 3c

Reports Q4 revenue $75.85M, consensus $69.69M. “Our 2025 performance reflects a pivotal year for Omada, marked by strong...

19d ago

OMDA

Omada Health sees FY26 revenue $312M-$322M, consensus $312.17M

Sees FY26 adjusted EBITDA $7M-$15M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

19d ago

OMDA

Omada Health price target lowered to $17 from $22 at Barclays

Barclays lowered the firm’s price target on Omada Health (OMDA) to $17 from $22 and keeps an Overweight...

21d ago

OMDA

Omada Health Earnings Call Highlights Profitable Growth

Omada Health, Inc. (($OMDA)) has held its Q4 earnings call. Read on for the main highlights of the...

14d ago

OMDA

Omada Health: Profitability Inflection, Double-Digit Growth Outlook, and Undervalued Upside Support Buy Rating

In a report released yesterday, David Roman from Goldman Sachs maintained a Buy rating on Omada Health, Inc.,...

18d ago

OMDA

OMDA Upcoming Earnings Report: What to Expect?

Omada Health, Inc. (OMDA) is scheduled to report 4th quarter earnings on 03/05/2026, after the market closes. Regarding...

21d ago

OMDA

Omada Health: Sentiment-Driven Sell-Off Creates Compelling Entry Point Amid Accelerating Growth and Limited Policy Risk

Canaccord Genuity analyst Richard Close has maintained their bullish stance on OMDA stock, giving a Buy rating on...

2M ago

OMDA

OMDA FAQ

What was Omada Health, Inc.’s price range in the past 12 months?

Omada Health, Inc. lowest stock price was $10.28 and its highest was $28.40 in the past 12 months.

What is Omada Health, Inc.’s market cap?

Omada Health, Inc.’s market cap is $796.08M.

When is Omada Health, Inc.’s upcoming earnings report date?

Omada Health, Inc.’s upcoming earnings report date is May 14, 2026 which is in 51 days.

How were Omada Health, Inc.’s earnings last quarter?

Omada Health, Inc. released its earnings results on Mar 05, 2026. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.009 by $0.071.

Is Omada Health, Inc. overvalued?

According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Omada Health, Inc. pay dividends?

Omada Health, Inc. does not currently pay dividends.

What is Omada Health, Inc.’s EPS estimate?

Omada Health, Inc.’s EPS estimate is -0.08.

How many shares outstanding does Omada Health, Inc. have?

Omada Health, Inc. has 58,925,438 shares outstanding.

What happened to Omada Health, Inc.’s price movement after its last earnings report?

Omada Health, Inc. reported an EPS of $0.08 in its last earnings report, beating expectations of $0.009. Following the earnings report the stock price went up 3.309%.

Which hedge fund is a major shareholder of Omada Health, Inc.?

Currently, no hedge funds are holding shares in OMDA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Omada Health, Inc. Stock Smart Score

Neutral

Company Description

Omada Health, Inc.

Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.

Omada Health, Inc. (OMDA) Earnings & Revenues

Historic Earnings Reports

OMDA Company Deck

OMDA Earnings Call

Q4 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call emphasized strong operational momentum in 2025 with substantial top-line growth (53%), scale in membership (886k, +55%), record margin expansion, first GAAP profitable quarter and positive full-year adjusted EBITDA—backed by product innovation (GLP-1 prescribing/Flex Care, cholesterol), AI deployment and peer-reviewed outcomes. Management provided prudent 2026 guidance (midpoint ~22% growth) that deliberately excludes early contributions from new products, which moderates near-term upside but reflects conservative planning. Near-term headwinds include seasonality-driven Q1 costs, a one-time Q4 revenue true-up, and the early-stage nature of new offerings; however, the balance of evidence points to durable commercial traction, improving unit economics and continued investment in scalable AI/product capabilities.View all OMDA earnings summaries

OMDA Stock 12 Month Forecast

Average Price Target

$22.67

▲(67.80% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","16":"$16","21":"$21","26":"$26","31":"$31"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$22.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$17.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,16,21,26,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.9,14.215384615384616,15.53076923076923,16.846153846153847,18.161538461538463,19.47692307692308,20.792307692307695,22.10769230769231,23.423076923076927,24.738461538461543,26.05384615384616,27.36923076923077,28.684615384615388,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.9,13.651538461538461,14.403076923076924,15.154615384615385,15.906153846153847,16.657692307692308,17.40923076923077,18.160769230769233,18.912307692307692,19.663846153846155,20.415384615384617,21.166923076923077,21.91846153846154,{"y":22.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.9,13.215384615384616,13.53076923076923,13.846153846153847,14.161538461538463,14.476923076923077,14.792307692307693,15.107692307692307,15.423076923076923,15.73846153846154,16.053846153846155,16.369230769230768,16.684615384615384,{"y":17,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.6,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.57,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.73,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.78,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.86,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.9,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >